US Patent 7402603 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination
Patent 7402603 was granted and assigned to Novartis on July, 2008 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 5, 2002
Date of Patent
July 22, 2008
Patent Application Number
10494221
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7402603 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
